Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement.
Hasan SA, Morsi M, Frakes BS, Bryson ME, Schmidt CW, Seshiah P, Choo J, Smith JM, Answini GA, Stewart-Dehner TL, Yasar SJ, Jollis JG, Berlacher MD, Ratajczak TM, Chung ES, Kereiakes DJ, Garcia S.
Hasan SA, et al.
Cardiovasc Revasc Med. 2024 Feb 10:S1553-8389(24)00023-X. doi: 10.1016/j.carrev.2024.02.002. Online ahead of print.
Cardiovasc Revasc Med. 2024.
PMID: 38355340